Abbott Laboratories shared the details from their earnings call for the third quarter of 2026.

Oct 21, 2026, 10:25 AM ETResultsRead the original at Benzinga

Good for ABT

Abbott reported 7% sales growth and 9% earnings-per-share growth, and expects sales growth to pick up after the split. Legal and payment challenges remain, but leaders said they do not expect them to disrupt the separation.

ABT · Abbott Laboratories

AI read · Good for ABT

The AI's read

The split could let each business focus on its own products and growth plans. Abbott also expects sales growth to pick up and profit margins to widen after the split. Legal disputes and payment issues remain, but leaders said they do not expect them to delay the plan.

Get alerts for ABT

Follow Abbott Laboratories (ABT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ABT

Free on the App Store and Google Play, or on the web.